B&P Mutual Corp — FDA Warning Letter, 2026-08-18: Foreign Supplier Verification Program (FSVP)
Letter issued · posted to fda.gov .
Subject as published: Foreign Supplier Verification Program (FSVP)
TL;DR
At a glance: The FDA issued an amended warning letter (CMS #734038) to B&P Mutual Corp on August 18, 2026, following an FSVP inspection conducted May 21–June 3, 2026, citing the company's failure to develop and maintain a Foreign Supplier Verification Program for Syrup and Molasses and Candy without Chocolate imported from foreign suppliers, in violation of section 805 of the FD&C Act and 21 CFR part 1, subpart L. The FDA found the company's June 22, 2026 response inadequate because it did not address corrective actions specific to the non-compliant products and requested written response within 15 working days with documentation of corrections, warning that further enforcement action including detention without physical examination or refusal of admission may follow.
Argus analysis
# FDA Warning Letter Analysis: B&P Mutual Corp
**Company and Findings**
B&P Mutual Corp, a food importer located in Hayward, California, received an amended Warning Letter from the FDA's Office of Inspections and Investigations on August 18, 2026. The agency conducted a Foreign Supplier Verification Program (FSVP) inspection between May 21 and June 3, 2026. FDA investigators determined that the company failed to develop and maintain required verification programs for imported Syrup and Molasses and Candy without Chocolate from foreign suppliers. The company's June 22, 2026 response addressed other product categories but provided no documentation addressing the specific violations identified.
**Regulatory Citations**
The violations center on section 805 of the Federal Food, Drug, and Cosmetic Act and the implementing regulation at 21 CFR Part 1, Subpart L. These requirements mandate that food importers perform risk-based verification activities to ensure imported products meet U.S. food safety standards. Specifically, 21 CFR 1.502(a) requires importers to develop, maintain, and follow an FSVP tailored to each product category and foreign supplier. The regulation operationalizes the Food Safety Modernization Act's importer accountability framework.
**Response Timeline and Industry Observations**
B&P Mutual Corp must respond within 15 working days with documentation demonstrating corrective actions. Compliance officers in the import food sector should monitor whether the company submits adequate FSVP documentation or whether FDA escalates enforcement. Potential next steps include detention without physical examination (DWPE) under Import Alert #99-41 for affected shipments, or refusal of entry under section 801(a)(3). Failure to respond adequately may result in FDA action prohibiting importation of non-compliant products.
Severity context
Low severity. Procedural or narrow scope; most peer companies resolve in the 15-business-day response window without structural change.
Regulatory background
FDA Warning Letters are administratively non-binding but signal that recurring non-compliance may escalate to injunction, seizure, import alert, or Application Integrity Policy invocation.
What peer compliance teams typically do next
Most compliance officers at peer companies use a Warning Letter against a named entity as a checklist for their own CAPA program. Common steps: pull the verbatim FDA letter; map each cited 21 CFR section against the team’s SOP library; confirm CAPA coverage; brief the QMR (Quality Management Review) on whether the cited subject matter is in scope for the next internal audit. The 15-business-day response window applies to the cited entity, not to peers — but a documented internal review against the cited subjects is what regulators expect to see if a peer is later inspected on the same topic.
Excerpt from the FDA Warning Letter (public domain, 17 USC §105)
WARNING LETTER B&P Mutual Corp MARCS-CMS 734038 — August 18, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Via Express Delivery Product: Food & Beverages Recipient: Recipient Name Jing Yang Recipient Title Owner B&P Mutual Corp 2557 Barrington Ct Hayward , CA 94545 United States (b)(6), (b)(7)(C) Issuing Office: Office of Inspections and Investigations United States August 18, 2026 AMENDED WARNING LETTER Re: CMS #734038 Dear Mr. Yang: We are amending our Warning Letter of July 16, 2026 to correct the name of the owner in the greeting of the letter. On May 21, 2026 through June 3, 2026, the Food and Drug Administration (FDA) conducted a Foreign Supplier Verification Program (FSVP) inspection of B&P Mutual Corp located at 2557 Barrington Ct, Hayward, CA 94545. This inspection was conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 384a) and the implementing FSVP regulation in 21 CFR part 1, subpart L. The FSVP regulation requires that importers perform certain risk-based activities to verify that human and/or animal food they import into the United States has been produced in a manner that meets applicable U.S. food safety standards. You may find information relating to the FSVP regulation and your responsibilities to comply with the regulation through links in FDA’s FSVP web page at https://www.fda.gov/food/food-safety-modernization-act-fsma/fsma-final-rule-foreign-supplier-verification-programs-fsvp-importers-food-humans-and-animals. During the inspection, we found that you are not in compliance with the requirements of 21 CFR part 1, subpart L for the following foods you import: Syrup and Molasses imported from (b)(4) located in (b)(4) and Candy without Chocolate imported from (b)(4) located in (b)(4) . Because of this significant violation, you are not in compliance with section 805 of the FD&C Act. At the conclusion of the inspection, our investigator provided you with a Form FDA 483a FSVP Observations. We acknowledge receipt of your response dated June 22, 2026 in which you indicated the documents in the response were the corrections to the Form FDA 483a. The documents included were the hazard analysis for the Soybean Paste and Noodle Soup Powder, (b)(4) foreign suppliers, onsite audit records for (b)(4) foreign suppliers, and Vendor Selection and Verification SOP. We are unable to evaluate the adequacy of your response because you have not provided any supporting documentation demonstrating your corrective actions to address the lack of FSVP for Syrup and Molasses imported from (b)(4) located in (b)(4) and Candy without Chocolate imported from (b)(4) located in (b)(4) . To date, no additional FSVP documents have been received by FDA. Your significant violation of the FSVP regulation is as follows: You did not develop, maintain, and follow an FSVP as required by section 805 of the FD&C Act and 21 CFR 1.502(a). …
Excerpt only. The full verbatim Warning Letter is the source of truth — always read the original before regulatory decisions.
The verbatim FDA Warning Letter is the source of truth. Always read the original before acting on any analysis or summary on this page.
Read the full letter on fda.gov ↗Frequently asked questions
- What FDA violations was B&P Mutual Corp cited for?
- The FDA Warning Letter to B&P Mutual Corp (issuing office: Office of Inspections and Investigations) cites: Foreign Supplier Verification Program (FSVP). Classification: Warning Letter.
- When did FDA issue the warning letter to B&P Mutual Corp?
- FDA issued the letter (MARCS-CMS 734038) on 2026-08-18 and posted it publicly on fda.gov on 2026-09-01.
- Is the FDA warning letter to B&P Mutual Corp publicly available?
- Yes. The full verbatim letter is published at fda.gov. Argus HQ links directly to the source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bp-mutual-corp-734038-08182026.
- What does a "low" severity rating mean for this letter?
- Low severity. Procedural or narrow scope; most peer companies resolve in the 15-business-day response window without structural change.
argus.hq
Don’t find out about the next one six weeks late.
Argus reads every FDA Warning Letter the day it publishes, summarizes it against your watchlist, and lands the ones touching your business in your inbox at 6am ET. Plans from $99/month. Cancel any time.
methodology
The analysis above is produced by Anthropic Claude Haiku 4.5 against the verbatim FDA Warning Letter excerpt and is brand-voice lint-checked before publish. The TL;DR is the same summary that ships in the customer email digest. Severity is auto-classified by Argus from the subject string and letter body using rules documented in lib/ingestion/fda-warning-letters.ts.
Argus HQ is informational only. Summaries and analyses are AI-generated and may contain errors, misclassifications, or omissions. Verify against the FDA source URL above. Argus HQ is not a law firm, accounting firm, or regulatory agency, and provides no legal, accounting, financial, medical, or regulatory advice.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). B&P Mutual Corp — FDA Warning Letter, 2026-08-18: Foreign Supplier Verification Program (FSVP). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/fda/warning-letter/fda-wl-b-and-p-mutual-corp-2026-08-18-warning-letter
"B&P Mutual Corp — FDA Warning Letter, 2026-08-18: Foreign Supplier Verification Program (FSVP)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/fda/warning-letter/fda-wl-b-and-p-mutual-corp-2026-08-18-warning-letter.
Argus HQ Research. "B&P Mutual Corp — FDA Warning Letter, 2026-08-18: Foreign Supplier Verification Program (FSVP)." Digital Empire Holdings LLC. Accessed September 4, 2026. https://argushq.ai/fda/warning-letter/fda-wl-b-and-p-mutual-corp-2026-08-18-warning-letter.
@misc{argushq_argushq_ai_fda_warning_letter_fda_wl_b_and_p_mutual_corp_2026_08_18_warning_letter_2026,
title = {B&P Mutual Corp — FDA Warning Letter, 2026-08-18: Foreign Supplier Verification Program (FSVP)},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/fda/warning-letter/fda-wl-b-and-p-mutual-corp-2026-08-18-warning-letter},
note = {Accessed: September 4, 2026}
}